UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver New anti-cancer therapies
File(s)UK drug approvals 2022 (final).docx (170.62 KB)
Accepted version
Author(s)
Lythgoe, Mark
Sullivan, Richard
Blagden, Sarah
Type
Journal Article
Date Issued
2023-09-01
Date Acceptance
2023-05-02
Citation
The Lancet Oncology, 2023, 24 (9), pp.963-966
ISSN
1213-9432
Publisher
Elsevier
Start Page
963
End Page
966
Journal / Book Title
The Lancet Oncology
Volume
24
Issue
9
Copyright Statement
© 2023 Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Publication Status
Published
Date Publish Online
2023-08-29